Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jon P. Stonehouse | CEO, President & Executive Director | 1.19M | 624.44k | 1961 |
| Ms. Alane P. Barnes | Senior VP, Chief Legal Officer & Corporate Secretary | 766.87k | -- | 1966 |
| Dr. Helen M. Thackray FAAP, M.D. | Chief Research & Development Officer | 941.91k | -- | 1968 |
| Mr. John D. Bluth | Chief Communications Officer | -- | -- | 1973 |
| Ms. Stephanie Angelini | Chief People Officer | -- | -- | -- |
| Dr. William P. Sheridan MBBS | Chief Development Officer | 756.59k | 4.25M | 1955 |
| Dr. Yarlagadda S. Babu Ph.D. | Chief Discovery Officer | 667.2k | 1.2M | 1953 |
| Ms. Jinky Ang Rosselli | Chief Data & Insights Officer | -- | -- | -- |
| Mr. Philip George | Chief Strategy Officer | -- | -- | -- |
| Mr. Clayton Fletcher | Chief Business Development Officer | -- | -- | -- |
BioCryst Pharmaceuticals, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 536
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Corporate Governance
Upcoming Events
February 24, 2025 at 1:30 PM UTC
BioCryst Pharmaceuticals, Inc. Earnings Date
Recent Events
Recent Events Information Not Available